middle.news
Neurotech’s NTI164 Gains FDA Rare Pediatric Disease Designation for Rett Syndrome
9:31am on Wednesday 8th of October, 2025 AEDT
•
Healthcare
Read Story
Neurotech’s NTI164 Gains FDA Rare Pediatric Disease Designation for Rett Syndrome
9:31am on Wednesday 8th of October, 2025 AEDT
Key Points
FDA grants Rare Pediatric Disease Designation for NTI164 in Rett syndrome
Designation complements existing Orphan Drug status
Access to FDA support, tax credits, and seven years market exclusivity
NTI164 is a cannabinoid-based neuroprotective compound
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NTI
OPEN ARTICLE